tiprankstipranks
Trending News
More News >
Neogen Corp (NEOG)
NASDAQ:NEOG
US Market

Neogen (NEOG) Earnings Dates, Call Summary & Reports

Compare
261 Followers

Earnings Data

Report Date
Apr 01, 2026
Before Open (Confirmed)
Period Ending
2026 (Q3)
Consensus EPS Forecast
0.06
Last Year’s EPS
-0.05
Same Quarter Last Year
Moderate Buy
Based on 4 Analysts Ratings

Earnings Call Summary

Q2 2026
Earnings Call Date:Jan 08, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presented several encouraging operational and financial signs: return to positive core revenue growth, meaningful sequential margin expansion (adjusted EBITDA margin +~470 bps), raised full-year guidance, demonstrated progress on Petrifilm integration, and enacted ~$20M of annualized cost savings. These positives were balanced against persistent macro headwinds (weaker food production and animal herd trends), elevated inventory write-offs, historical sample collection drag (improving), and substantial remaining leverage ($800M gross debt). Management emphasized conservative guidance and disciplined execution. On balance, the call conveyed material early progress and constructive momentum while acknowledging important execution and market risks that are being actively managed.
Company Guidance
Management raised fiscal 2026 guidance to revenue of $845–$855 million and adjusted EBITDA of about $175 million (roughly a 20.6% margin at the midpoint), while reiterating full‑year CapEx of ~$50 million and positive free cash flow; they expect routine CapEx to normalize to 3–4% of revenue late in FY26. The upgrade was driven by Q2 results of $224.7 million revenue (core +2.9%), adjusted EBITDA $48.7 million (21.7% margin, +470 bps sequential), adjusted net income $22.6 million and adjusted EPS $0.10, gross margin 47.5% (50.3% excluding integration/restructuring), and Q2 free cash flow of $7.8 million. Management said cost actions implemented in Q2 should deliver about $20 million of annualized savings, noted gross debt of $800 million with $145.3 million of cash (68% of debt fixed rate), expects Q4 revenue modestly above Q3 (with Q3 stepping down from Q2) and margins to follow a similar pattern, and flagged the genomics divestiture process (announcement anticipated in Q4) and Petrifilm integration on track for 2027.
Return to Positive Core Revenue Growth
Total Q2 revenue of $224.7M with core revenue growth of 2.9% (foreign currency +0.9%; divestitures/discontinued products headwind -6.6%).
Food Safety Segment Strength
Food Safety revenue of $165.6M with core revenue growth of 4.1%; indicator testing/culture media and sample collection were key drivers, and PetriFilm returned to high-single-digit growth.
Genomics and Regional Performance
Global genomics core revenue growth accelerated to 6% in the quarter. Regional core growth led by LatAm (high-single-digits); U.S./Canada mid-single-digits; APAC low-single-digits; EMEA slight decline (low-single-digits).
Margin and Profitability Improvement
Adjusted EBITDA of $48.7M (margin 21.7%) — a sequential improvement of ~470 basis points. Adjusted net income $22.6M and adjusted EPS $0.10 versus $9.4M and $0.04 in the prior quarter (adjusted net income up ~140%, EPS up 150%).
Gross Margin Recovery
Reported gross margin improved to 47.5% (sequential improvement of ~210 bps); excluding integration/restructuring items gross margin was 50.3%.
Cost Actions and Operational Savings
Q2 cost structure improvements implemented are expected to deliver approximately $20M of annualized savings; a headcount reduction contributed to margin expansion.
Petrifilm Integration Progress
Petrifilm integration remains on track for the previously disclosed 2027 timeline — late-stage production testing completed well and initial product validation underway; ability to manufacture Petrifilm plates has been demonstrated.
Balance Sheet and Cashflow Improvements
Gross debt of $800M (68% fixed) and cash of $145.3M; prior Cleaners & Disinfectants divestiture enabled $100M debt paydown. Q2 free cash flow was $7.8M, improving $20.9M from Q1. Management expects FY CapEx ~$50M and routine CapEx trending to 3–4% of revenue.
Guidance Raised
Management raised full-year fiscal 2026 guidance: revenue now expected $845M–$855M and adjusted EBITDA approximately $175M, reflecting Q2 outperformance.
Leadership and Commercial Execution
Strengthened senior leadership (new CFO, CCO, and other senior hires) and implemented process-driven commercial changes (weekly LBE forecasting, solutions-based selling) credited with improved predictability and sales execution.

Neogen (NEOG) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

NEOG Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 01, 2026
2026 (Q3)
0.06 / -
-0.05
Jan 08, 2026
2026 (Q2)
0.06 / 0.10
-2.1104.76% (+2.20)
Oct 09, 2025
2026 (Q1)
-0.07 / 0.04
-0.06166.67% (+0.10)
Jul 29, 2025
2025 (Q4)
-0.05 / -2.82
-0.02-14000.00% (-2.80)
Apr 09, 2025
2025 (Q3)
-0.02 / -0.05
-0.01-400.00% (-0.04)
Jan 10, 2025
2025 (Q2)
-0.01 / -2.10
-0.02-10400.00% (-2.08)
Oct 10, 2024
2025 (Q1)
-0.03 / -0.06
0.01-700.00% (-0.07)
Jul 30, 2024
2024 (Q4)
-0.01 / -0.02
0.03-166.67% (-0.05)
Apr 09, 2024
2024 (Q3)
0.01 / -0.01
0.04-125.00% (-0.05)
Jan 09, 2024
2024 (Q2)
0.03 / -0.02
-0.1989.47% (+0.17)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

NEOG Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Jan 08, 2026
$7.38$9.71+31.57%
Oct 09, 2025
$5.82$6.78+16.49%
Jul 29, 2025
$5.42$4.83-10.89%
Apr 09, 2025
$7.04$5.02-28.69%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Neogen Corp (NEOG) report earnings?
Neogen Corp (NEOG) is schdueled to report earning on Apr 01, 2026, Before Open (Confirmed).
    What is Neogen Corp (NEOG) earnings time?
    Neogen Corp (NEOG) earnings time is at Apr 01, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is NEOG EPS forecast?
          NEOG EPS forecast for the fiscal quarter 2026 (Q3) is 0.06.